Baxter International Inc at Raymond James Institutional Investors Conference Transcript
All right. Good morning, everyone, and thank you for attending us at the Annual Raymond James Institutional Investors Conference. I'm Larry Keusch, the hospital supply analyst.
We're extremely excited to have with us for the next presentation, Baxter. Baxter continues to be a favorite name of ours. We really like the accelerating organic growth profile for the company over the next several years; the continued margin expansion; and obviously, the opportunity for capital deployment given the strength of the balance sheet. Execution has been pretty steady for this company over a number of years, and we don't see anything deviating for that going forward in the future.
With us today is Jay Saccaro. Jay is Executive Vice President and Chief Financial Officer; and then Clare Trachtman, who is Vice President of Investor Relations.
So we'll do some prepared comments and then have a little bit of time here for Q&A. And then management will be available downstairs in the Amarante 1 room.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
